Josh White Sharecast News 07 Dec, 2023 13:11 07 Dec, 2023 13:11 Shield Therapeutics reports strong US progress Iron deficiency-focussed pharmaceuticals company Shield Therapeutics announced significant achievements in the US commercialisation of Accrufer on Thursday.